These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 17919226)

  • 1. Treating nonalcoholic fatty liver disease.
    Méndez-Sánchez N; Arrese M; Zamora-Valdés D; Uribe M
    Liver Int; 2007 Nov; 27(9):1157-65. PubMed ID: 17919226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease.
    Hjelkrem MC; Torres DM; Harrison SA
    Minerva Med; 2008 Dec; 99(6):583-93. PubMed ID: 19034256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
    Jansen PL
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease as a complication of insulin resistance.
    Abdelmalek MF; Diehl AM
    Med Clin North Am; 2007 Nov; 91(6):1125-49, ix. PubMed ID: 17964913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease: from clinical recognition to treatment.
    Sevastianos VA; Hadziyannis SJ
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):59-79. PubMed ID: 19072371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management.
    Lemoine M; Serfaty L; Capeau J
    Curr Opin Infect Dis; 2012 Feb; 25(1):10-6. PubMed ID: 22183113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approach to the diagnosis and treatment of nonalcoholic fatty liver disease.
    Ong JP; Younossi ZM
    Clin Liver Dis; 2005 Nov; 9(4):617-34, vi. PubMed ID: 16207567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harrison SA; Neuschwander-Tetri BA
    Clin Liver Dis; 2004 Nov; 8(4):861-79, ix. PubMed ID: 15464659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease.
    Adams LA; Angulo P; Lindor KD
    CMAJ; 2005 Mar; 172(7):899-905. PubMed ID: 15795412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and management of obesity-related nonalcoholic fatty liver disease.
    Nugent C; Younossi ZM
    Nat Clin Pract Gastroenterol Hepatol; 2007 Aug; 4(8):432-41. PubMed ID: 17667992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease.
    Angulo P
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.
    Carter-Kent C; Zein NN; Feldstein AE
    Am J Gastroenterol; 2008 Apr; 103(4):1036-42. PubMed ID: 18177455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C infection and nonalcoholic fatty liver disease.
    Cheung O; Sanyal AJ
    Clin Liver Dis; 2008 Aug; 12(3):573-85, viii-ix. PubMed ID: 18625429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric nonalcoholic fatty liver disease.
    Lerret SM; Skelton JA
    Gastroenterol Nurs; 2008; 31(2):115-9. PubMed ID: 18391799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C and nonalcoholic fatty liver disease.
    Ramesh S; Sanyal AJ
    Semin Liver Dis; 2004 Nov; 24(4):399-413. PubMed ID: 15605308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment.
    Milić S; Stimac D
    Dig Dis; 2012; 30(2):158-62. PubMed ID: 22722431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fat and the liver--a molecular overview.
    Harrison SA; Diehl AM
    Semin Gastrointest Dis; 2002 Jan; 13(1):3-16. PubMed ID: 11944631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease and the metabolic syndrome.
    Marchesini G; Babini M
    Minerva Cardioangiol; 2006 Apr; 54(2):229-39. PubMed ID: 16778754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
    Miele L; Forgione A; Hernandez AP; Gabrieli ML; Vero V; Di Rocco P; Greco AV; Gasbarrini G; Gasbarrini A; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):273-7. PubMed ID: 16231589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
    Rafiq N; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.